IL33 and colitis: On the one hand, IL-33 is considered to aggravate intestinal pathology, but on the other hand, it has been shown that IL-33 is able to attenuate colitis development (12, 14, 25, 26), a characteristic of IL-33 that was also observed for other disease patterns (27–30).